surmount-1 trial tirzepatide weight loss non-diabetic after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Read now: The SURPASS-EARLY trial

In 2020, the FDA approved the use of Saxenda for treating obesity in children as young as 12 years old

Manufacturer's Disclaimer If you are pregnant, nursing or taking any prescription medication, consult your doctor before use

Supplements are stronger than the carnitine you get from food

No studies have confirmed a link between GLP-1 medications and thyroid tumors in humans, but if you have a history of family thyroid cancer, you may want to discuss taking a GLP-1 with your primary care provider

By some estimates, a quarter of the world's GDP in some way relies on quantum mechanics

The medication is administered as a once-weekly subcutaneous injection, starting with a low dose (0.25 mg) that is gradually increased over 16 weeks to the maintenance dose of 2.4 mg